VAERS reports by lot

GSK Varicella/Shingles lot 32GR4: VAERS reports

130 VAERS reports list lot 32GR4 as a GSK Varicella/Shingles vaccine, received between 2018-05-18 and 2019-06-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
130
Reports
3%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)13926%
Injection-site / Local reaction13626%
Dermatological (non-injection-site)5711%
Neurological469%
Musculoskeletal428%
Cardiac / Cardiovascular387%
Gastrointestinal326%
Allergic / Anaphylactic194%
Psychiatric / Neuropsychiatric112%
Autoimmune / Immune-mediated51%
Respiratory51%
Thrombotic / Hematological20%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida18
Maryland12
Massachusetts11
Pennsylvania8
Georgia7
New York7
Kansas6
South Carolina6
California5
New Jersey4
West Virginia3
Vermont3

Reports by month received

2018-0515
2018-0658
2018-0731
2018-0812
2018-094
2018-105
2018-112
2018-121
2019-011
2019-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.